Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response. [PDF]
Mezzanotte V+14 more
europepmc +1 more source
Cost‐effectiveness of imatinib versus interferon‐α plus low‐dose cytarabine for patients with newly diagnosed chronic‐phase chronic myeloid leukemia [PDF]
Shelby D. Reed+4 more
openalex +1 more source
From low remission to hope: the efficacy of targeted therapies in NUP98-R positive pediatric acute myeloid leukemia. [PDF]
Xiong RJ+4 more
europepmc +1 more source
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate‐cytarabine regimen [PDF]
Abdullah Büyükçelik+3 more
openalex +1 more source
Clinical outcomes and therapeutic modalities in older Chinese patients with MCL: a multi-center real-world retrospective study. [PDF]
Yang Y+18 more
europepmc +1 more source
Granulocyte‐macrophage colony‐stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial [PDF]
Christina Löfgren+12 more
openalex +1 more source
Venetoclax combination with Cladribine, idarubicin, Cytarabine for relapsed T-Cell acute lymphoblastic leukemia/lymphoblastic lymphoma treatment: A case report and literature review. [PDF]
Yahia AE+7 more
europepmc +1 more source
The Mechanism of Synergistic Interaction between Etoposide and Cytarabine
Kazuya Ooi
openalex +2 more sources
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene [PDF]
Tülin Budak‐Alpdogan+5 more
openalex +1 more source
Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia. [PDF]
Liu Q+8 more
europepmc +1 more source